Allogene Therapeutics, Inc. (ALLO) — DEFA14A Filings
All DEFA14A filings from Allogene Therapeutics, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Allogene Therapeutics Files Proxy Materials
— Apr 30, 2025 Risk: low
Allogene Therapeutics, Inc. filed a Definitive Additional Materials (DEFA14A) on April 30, 2025, related to its proxy statement. The filing concerns the company
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX